Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis

Details for Australian Patent Application No. 2008257455 (hide)

Owner PULEVA BIOTECH, S.A.

Inventors Rodriguez Gomez, Juan Miguel; Marin Martinez, Maria Luisa; Martin Jimenez, Rocio; Martin Merino, Virginia; Maldonado Barragan, Antonio; Torre Lloveras, Celina; Fernandez Alvarez, Leonides; Delgado Palacio, Susana; Jimenez Lopez, Jesus; Sobrino Abuja, Odon Julian; Olivares Martin, Monica; Xaus Pei, Jordi; Sierra Avila, Saleta; Lara Villoslada, Federico; Arroyo Rodriguez, Rebeca; Blanch Martell, Francesc; Jimenez Quintana, Esther Antonia; Boza Puerta, Julio

Agent Collison & Co

Pub. Number AU-A-2008257455

PCT Pub. Number WO2008/145756

Priority 07380158.1 31.05.07 EP

Filing date 2 June 2008

Wipo publication date 4 December 2008

International Classifications

A61K 35/74 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A23C 9/12 (2006.01) Dairy products - Fermented milk preparations

A23L 1/03 (2006.01) Foods or foodstuffs - containing additives

C12Q 1/24 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - Methods of sampling, or inoculating or spreading a sample

C12R 1/225 (2006.01)

C12R 1/25 (2006.01)

Event Publications

24 December 2009 PCT application entered the National Phase

  PCT publication WO2008/145756 Priority application(s): WO2008/145756

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008257460-Yield enhancement in plants by modulation of GARP transcripton factor ZmRR10_p

2008257448-Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders